Dr. Christoph L. Bausch
Chief Science Officer
As Chief Science Officer, Dr. Bausch is responsible for antibody and antigen production, quality control laboratories, research collaborations, grant funding and clinical studies.
Dr. Bausch is an experienced research scientist, biotech entrepreneur and business development executive who has led the successful discovery, development and commercialization of platform technologies in the life science space.
Prior to SAB, Dr. Bausch served in several business development positions most recently for $7B global biorefining leader, Poet, LLC, where he structured strategic partnerships, prospected and vetted new technologies, and streamlined research and development. He also worked in both research and commercialization roles for Fortune 500 life science company, Sigma-Aldrich.
A molecular microbiologist by training, Dr. Bausch has extensive technical expertise in bioprocessing optimization, molecular genetics, microbial engineering and product development. He is also a seasoned entrepreneur having founded Nanopore Diagnostics, LLC, a next generation microbial diagnostic company.
He remains a strategic advisor to Nanopore in addition to the BioSNTR, a statewide academic and industry collaborative research endeavor focused on impact science.
Dr. Bausch received his Ph.D. in Microbiology at The Ohio State University; Columbus, Ohio, completed Post Doctoral Training at the Stowers Institute for Medical Research, Kansas City, Missouri and earned an M.B.A. from St. Louis University, St. Louis, Missouri in addition to a B.A. in Biology from the University of Nebraska-Lincoln, Lincoln, Nebraska.